Dr. Hans-Joachim Schmoll

Rectal cancer therapy without surgery. Future of Colorectal cancer treatment. 10

Rectal cancer therapy without surgery. Future of Colorectal cancer treatment. 10

Every cancer patient must be evaluated by Tumor Board. Multidisciplinary Team. 9-2

Every cancer patient must be evaluated by Tumor Board. Multidisciplinary Team. 9-2

Quality of treatment of colorectal cancer varies greatly. 9-1

Quality of treatment of colorectal cancer varies greatly. 9-1

Liquid biopsy in colorectal cancer. Precision diagnosis and treatment. 8-2

Liquid biopsy in colorectal cancer. Precision diagnosis and treatment. 8-2

Colorectal cancer prognosis. Adaptive clinical trials. Prediction of response to treatment. 8-1

Colorectal cancer prognosis. Adaptive clinical trials. Prediction of response to treatment. 8-1

Stage 4 colon cancer. Liver or lung metastases. Locoregional treatment. DEBIRI TACE, IRE, SIRT. 7

Stage 4 colon cancer. Liver or lung metastases. Locoregional treatment. DEBIRI TACE, IRE, SIRT. 7

Colorectal cancer chemotherapy in elderly. Choose treatment based on fitness. 6

Colorectal cancer chemotherapy in elderly. Choose treatment based on fitness. 6

Chemotherapy of rectal cancer. Capecitabine (Xeloda) and oxaliplatin 5-FU. Controversies. 5-3

Chemotherapy of rectal cancer. Capecitabine (Xeloda) and oxaliplatin 5-FU. Controversies. 5-3

Capecitabine (Xeloda) therapy efficacy prediction. DPD enzyme gene expression in colon cancer. 5-2

Capecitabine (Xeloda) therapy efficacy prediction. DPD enzyme gene expression in colon cancer. 5-2

Stage 3 colon cancer treatment. Capecitabine (Xeloda) and 5-Fluorouracil (5-FU). 5-1

Stage 3 colon cancer treatment. Capecitabine (Xeloda) and 5-Fluorouracil (5-FU). 5-1

Treatment of colorectal cancer with HER2 inhibitors. Herceptin and Lapatinib (Tykerb). 4-2

Treatment of colorectal cancer with HER2 inhibitors. Herceptin and Lapatinib (Tykerb). 4-2

Precision chemotherapy of colorectal cancer. EGFR, BRAF, MEK inhibitors. 4-1

Precision chemotherapy of colorectal cancer. EGFR, BRAF, MEK inhibitors. 4-1

Colorectal cancer immunotherapy. Which patients benefit most? 3-2

Colorectal cancer immunotherapy. Which patients benefit most? 3-2

Colorectal cancer stem cells. Immunotherapy of colon cancer. 3-1

Colorectal cancer stem cells. Immunotherapy of colon cancer. 3-1

Precision treatment of colon cancer. Patient’s genetic profile is important. 2-2

Staging of colorectal cancer. Molecular cancer classification for precision treatment of tumors. 2-1

Staging of colorectal cancer. Molecular cancer classification for precision treatment of tumors. 2-1

Colon cancer screening. Which test is most effective? Tumor DNA tests from feces and blood. Part 2 of 2. 1-2

Colon cancer screening. Which test is most effective? Tumor DNA tests from feces and blood. Part 2 of 2. 1-2

Colon cancer screening. Which test is most effective? Part 1 of 2. Colonoscopy. 1-1

Colon cancer screening. Which test is most effective? Part 1 of 2. Colonoscopy. 1-1

Dr. Hans-Joachim Schmoll. Colorectal cancer expert. Biography. 0

Dr. Hans-Joachim Schmoll. Colorectal cancer expert. Biography. 0